Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254995 · ClinicalTrials.gov registry record
Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 62,626
- Enrollment target
NCT00254995 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 62,626 participants.
The verdict
NCT00254995 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 62,626 participants
- Enrollment target
Study Summary
To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Interventions
- BIOLOGICAL None administered in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62,626 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00254995
The ClinicalTrials.gov registry entry for NCT00254995 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62,626 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which None administered in this study is the first listed.
NCT00254995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00254995 about?
NCT00254995 is a clinical study titled "Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine". To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
What is the current status of trial NCT00254995?
This trial is currently completed. The enrollment target is 62,626 participants. The study started on 2005-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00254995?
The interventions under investigation include: None administered in this study (BIOLOGICAL).
Who is sponsoring clinical trial NCT00254995?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.